Coimbra Genomics Company

Coimbra Genomics, S.A. has developed and is commercializing ELSIE, a first-in-class digital platform that allows physicians of any speciality to use information on their patient’s genome during a regular medical appointment. By combining the capacity to provide fast, accurate, on-the-spot answers based on each patient’s genome with an efficient articulation with multiple providers of specific genetic tests, ELSIE is the first simple, highly scalable and completely secure way to perform personalized medicine.
Technology: Others
Industry: Biotechnology, Health Care, Science and Engineering
Headquarters: Cantanhede, Coimbra, Portugal
Founded Date: 2013-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 3
Total Funding: €4.7M
Estimated Revenue: $1M to $10M
Last Funding Type: Series A

Visit Website
Register and Claim Ownership